These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 15950391

  • 1. Depressive disorders -- is it time to endorse different pathophysiologies?
    Antonijevic IA.
    Psychoneuroendocrinology; 2006 Jan; 31(1):1-15. PubMed ID: 15950391
    [Abstract] [Full Text] [Related]

  • 2. HPA axis and sleep: identifying subtypes of major depression.
    Antonijevic I.
    Stress; 2008 Jan; 11(1):15-27. PubMed ID: 17853067
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states.
    Gold PW, Chrousos GP.
    Mol Psychiatry; 2002 Jan; 7(3):254-75. PubMed ID: 11920153
    [Abstract] [Full Text] [Related]

  • 5. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E, Schmid D, Modell S, Brunner H, Lauer CJ, Holsboer F, Ising M.
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [Abstract] [Full Text] [Related]

  • 6. Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity.
    Kaestner F, Hettich M, Peters M, Sibrowski W, Hetzel G, Ponath G, Arolt V, Cassens U, Rothermundt M.
    J Affect Disord; 2005 Aug; 87(2-3):305-11. PubMed ID: 15951024
    [Abstract] [Full Text] [Related]

  • 7. Mice selected for high versus low stress reactivity: a new animal model for affective disorders.
    Touma C, Bunck M, Glasl L, Nussbaumer M, Palme R, Stein H, Wolferstätter M, Zeh R, Zimbelmann M, Holsboer F, Landgraf R.
    Psychoneuroendocrinology; 2008 Jul; 33(6):839-62. PubMed ID: 18502051
    [Abstract] [Full Text] [Related]

  • 8. Changes in hypothalamic-pituitary-adrenal axis measures after vagus nerve stimulation therapy in chronic depression.
    O'Keane V, Dinan TG, Scott L, Corcoran C.
    Biol Psychiatry; 2005 Dec 15; 58(12):963-8. PubMed ID: 16005439
    [Abstract] [Full Text] [Related]

  • 9. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
    Psychoneuroendocrinology; 2009 Jan 15; 34(1):99-109. PubMed ID: 18829172
    [Abstract] [Full Text] [Related]

  • 10. Impact of gene-gender effects of adrenergic polymorphisms on hypothalamic-pituitary-adrenal axis activity in depressed patients.
    Haefner S, Baghai TC, Schule C, Eser D, Spraul M, Zill P, Rupprecht R, Bondy B.
    Neuropsychobiology; 2008 Jan 15; 58(3-4):154-62. PubMed ID: 19088492
    [Abstract] [Full Text] [Related]

  • 11. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C, Vermetten E, Lentjes E, Geuze E, van Pelt J, Manuel R, Heijnen C, Westenberg H.
    Psychoneuroendocrinology; 2008 Apr 15; 33(3):313-20. PubMed ID: 18215470
    [Abstract] [Full Text] [Related]

  • 12. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A.
    J Psychiatr Res; 2009 Apr 15; 43(7):702-10. PubMed ID: 19038406
    [Abstract] [Full Text] [Related]

  • 13. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression.
    Steimer T, Python A, Schulz PE, Aubry JM.
    Psychoneuroendocrinology; 2007 Jun 15; 32(5):575-9. PubMed ID: 17512120
    [Abstract] [Full Text] [Related]

  • 14. Electroencephalographic sleep profiles in treatment course and long-term outcome of major depression: association with DEX/CRH-test response.
    Hatzinger M, Hemmeter UM, Brand S, Ising M, Holsboer-Trachsler E.
    J Psychiatr Res; 2004 Jun 15; 38(5):453-65. PubMed ID: 15380395
    [Abstract] [Full Text] [Related]

  • 15. Do anxiety and depression have a common pathophysiological mechanism?
    Boyer P.
    Acta Psychiatr Scand Suppl; 2000 Jun 15; (406):24-9. PubMed ID: 11131467
    [Abstract] [Full Text] [Related]

  • 16. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
    Psychoneuroendocrinology; 2008 Feb 15; 33(2):152-61. PubMed ID: 18068306
    [Abstract] [Full Text] [Related]

  • 17. Psychobiological differences between depression and somatization.
    Rief W, Hennings A, Riemer S, Euteneuer F.
    J Psychosom Res; 2010 May 15; 68(5):495-502. PubMed ID: 20403510
    [Abstract] [Full Text] [Related]

  • 18. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
    Papiol S, Arias B, Gastó C, Gutiérrez B, Catalán R, Fañanás L.
    J Affect Disord; 2007 Dec 15; 104(1-3):83-90. PubMed ID: 17467808
    [Abstract] [Full Text] [Related]

  • 19. The stress system in depression and neurodegeneration: focus on the human hypothalamus.
    Bao AM, Meynen G, Swaab DF.
    Brain Res Rev; 2008 Mar 15; 57(2):531-53. PubMed ID: 17524488
    [Abstract] [Full Text] [Related]

  • 20. Incorporating hypothalamic-pituitary-adrenal axis measures into preventive interventions for adolescent depression: are we there yet?
    Adam EK, Sutton JM, Doane LD, Mineka S.
    Dev Psychopathol; 2008 Mar 15; 20(3):975-1001. PubMed ID: 18606040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.